United States · 
Who invested in Lyell Immunopharma?
Lyell Immunopharma's investors include ARCH Venture Partners and Mubadala.
United States · Funded startup
Who invested in Lyell Immunopharma
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $100MJul 2025
- Investors
- 2
The rounds
- Jul 2025
Founders and team
From the SEC filings it signed: 8 on the team.
- Elizabeth HomansExecutive Officeri
- Heather TurnerExecutive Officeri
- Margo RobertsExecutive Officeri
- Nicholas RestifoExecutive Officeri
- Richard GooldExecutive Officeri
- Richard KlausnerExecutive Officer, Director, Promoteri
- Stan RiddellExecutive Officeri
- Stephen HillExecutive Officeri
On the board, as filediCatherine FriedmanHans BishopRobert Nelson
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Lyell Immunopharma
How much has Lyell Immunopharma raised?
Lyell Immunopharma has raised $100M across 1 round since 2025.
When did Lyell Immunopharma last raise?
Lyell Immunopharma's most recent round was an Undisclosed round of $100M in Jul 2025.
What was Lyell Immunopharma's biggest round?
Its most recent round, $100M in Jul 2025, is also its largest on record.
Who backed Lyell Immunopharma first?
Lyell Immunopharma's first round on record, in Jul 2025, was backed by ARCH Venture Partners and Mubadala.
What stage is Lyell Immunopharma at?
Lyell Immunopharma's latest named round is an Undisclosed round, in Jul 2025.
Where is Lyell Immunopharma based?
Lyell Immunopharma is based in the United States.
Companies like Lyell Immunopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.